NetScientific plc Director/PDMR Shareholding NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation group, announced on 22 June 2022, that…
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR…
RNS REACH NetScientific plc ("NetScientific", the "Group" or the "Company") NetScientific to increase Q-Bot stake to 23.7% NetScientific plc (AIM: NSCI),…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth NetScientific plc (AIM:…
06 June 2022 NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech presents new data for two ongoing clinical trials NetScientific plc (AIM:…
NetScientific plc (“NetScientific” or the “Company”) General Counsel Strategic Hire and Grant of Options NetScientific plc (AIM: NSCI), the international life…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) ProAxsis Update ProAxsis announces “impressive” results in performance evaluation of the in-licensed AstraZeneca…
NetScientific plc ("NetScientific", “NSCI”, the Group” or the "Company") Preliminary Results for the year ended 31 December 2021 Good results demonstrate…
11th May 2022 NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial…
NetScientific plc ("NetScientific", the "Group" or the "Company") Notice of Results Investor Presentation NetScientific plc (AIM: NSCI), the international life sciences and…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Acquisition of 30% of Vortex Biotech Holdings NetScientific plc (AIM: NSCI), the international…
NetScientific plc ("NetScientific" or the "Group") PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2021 Financial Results London, UK –…
NetScientific Q1 2022 Newsletter (Click to view full Newsletter) Dear NetScientific PLC Shareholders and Stakeholders, In advance of the annual report…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Preliminary Safety Data on PDS0101 in Combination With Merck’s anti PD-therapy…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine London, UK – 28…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) ProAxsis CEO End of Year Update London, UK – 10 January 2022 – NetScientific plc (AIM:…
NetScientific plc ("NetScientific", the "Group" or the "Company") Q-Bot Investment and Share Acquisition NetScientific takes c.19% direct stake in construction industry robotics…
NetScientific plc ("NetScientific", the “Group” or the "Company") Acquisition of majority stake in Cetromed Investment in Cetromed subsidiary FOx Biosystems NetScientific…
NetScientific plc ("NetScientific", the “Group” or the "Company") Martlet Capital Update EMVC syndicates additional £0.73m investment Syndication highlights strength of capital…
NetScientific plc ("NetScientific", the “Group” or the "Company") $1million investment in portfolio company, EpiBone London, UK – 26 November 2021 – NetScientific…
NetScientific plc ("NetScientific", the “Group” or the "Company") Sofant Signs €7.3m European Space Agency Contract London, UK – 4 November 2021 – NetScientific…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Biotech Announces Agreement with University of Georgia to License Novel Proteins for Versamune-based…
NetScientific plc ("NetScientific", the “Group” or the "Company") EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer…
ProAxsis, one of NetScientific's portfolio companies specialized in the Life Sciences sector, has just presented its new NEATstik product which has been…
NetScientific plc ("NetScientific" or the "Company") Director/PDMR Shareholding London, UK – 16 July 2021 – NetScientific plc (AIM: NSCI), the international life sciences…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Closing of Approximately $52 Million Public Offering and Full Exercise…
Chairman John Clarkson said: “In what has been a challenging year for ProAxsis, positive management actions have helped transform the company’s outlook"
"This placement provides further impetus behind our model of 'capital-light' investment combined with pro-active management and value-added support to our portfolio," said…
NetScientific plc ("NetScientific", the "Group" or the "Company") NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction London,…
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical…
NetScientific plc ("NetScientific" or the "Group") ProAxsis Update ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test London, UK –…
NetScientific plc ("NetScientific" or the "Group") ProAxsis Update Following transformative year ProAxsis focuses on delivering revenues and profitability London, UK – 24…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results London,…
NetScientific plc ("NetScientific", the "Group" or the "Company") EMV Capital advised on £2.9m funding for anaesthetic gas recycling tech business SageTech…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at…
NetScientific plc ("NetScientific", the “Group” or the "Company") EMV Capital advised on £740k oversubscribed funding round for 5G and satellite phased array…
NetScientific plc ("NetScientific", “NSCI”, the Group” or the "Company") Preliminary Results for the year ended 31 December 2020 Company poised for further…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS COVID-19 Vaccine Commercialisation Update c. $60m Funding Commitment by Brazilian government for Clinical…
NetScientific plc ("NetScientific" or the "Company") ProAxsis Update London, UK – 22 February 2021 – NetScientific plc (AIM: NSCI), the life sciences and…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Preliminary Efficacy Achievement in Phase II Combination Trial of PDS0101 Led by…
NetScientific plc ("NetScientific" or the "Company") Suspension of Trading on AIM NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation…
NetScientific plc ("NetScientific" or the "Company") Issue of Shares, Director/PDMR Shareholding and Total Voting Rights NetScientific plc (AIM: NSCI), the life sciences,…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19…
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients…
NetScientific plc (“NetScientific” or the “Company”) NetScientific’s EMV Capital Ltd leads a £1.28m pre-Series A round in SageTech Medical Equipment Ltd…
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited appoints DiaPharma as distributor to key North America region London, UK – 19 November…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine PDS0203 prioritized for clinical…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck…
NetScientific plc ("NetScientific" or the "Company") NetScientific plc NetScientific acquires 100% control of portfolio company ProAxsis Limited London, UK – 16 October…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.